摘要 |
The present invention concerns regulation of complement activation, in particular the fluid phase regulation of complement activation, and provides molecules comprising at least complement control protein modules 1-4 of complement factor H, DNA molecules encoding same, their use in the manufacture of a medicament for inhibiting complement activation and methods of same, together with DNA sequences encoding rat FH 4.3 and 1.0 kb mRNA.
|